Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $304.9400 (-0.98%) ($303.7000 - $309.2100) on Fri. May. 17, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.02% (three month average) | RSI | 25 | Latest Price | $304.9400(-0.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.5% a day on average for past five trading days. | Weekly Trend | REGN declines -5.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(47%) IVW(41%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -1.01% in a week (0% probabilities). VXX(-11%) TLT(-6%) IFRA(-6%) TIP(-1%) IGOV(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.01% (StdDev 2.02%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
Resistance Level | $327.88 | 5 Day Moving Average | $305.65(-0.23%) | 10 Day Moving Average | $315.48(-3.34%) | 20 Day Moving Average | $327.88(-7%) | To recent high | -30.6% | To recent low | 0.1% | Market Cap | $32.332b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |